Blog

Perspectives in Breast and Colorectal Cancer Research


NSABP Foundation

Jame Abraham, MD, discusses the importance of patient participation in clinical trials

By Dr. Jame Abraham, Director, Breast Oncology Program, Taussig Cancer Institute, Cleveland Clinic

Watch this inspirational video with Dr. Jame Abraham, Director of the Breast Oncology program at Taussig Cancer Institute and Co-Director of the Cleveland Clinic Lerner College of Medicine, as he shares his experience and insight into the importance of clinical trials, their accrual rates and the phase I and phase II trials with neratinib. Dr. Abraham also discusses the crucial role that doctors have in helping patients decide to take part in clinical trials, which are so important in the progress of cancer treatment.

Previous Article Exploring the Great Unknown with Dr. Tatjana Kolevska
Next Article Peter Lucas, MD, discusses the use of correlative science post-clinical trials
Print
6148

Name:
Email:
Subject:
Message:
x